Ligand Pharmaceuticals Incorporated LGND

301.52 2.48 0.83% as of 25 Sep

Market cap: $6.1B
P/E: 30.1×

Follow LGND

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16
P/E ratio Full definition →	30.01	0.00	23.79	0.00	27.85	0.00	2.13	12.54	144.13	0.00
P/S ratio Full definition →	13.64	11.73	9.53	5.68	6.63	6.14	10.27	7.12	12.89	12.22
P/FCF ratio Full definition →	60.02	21.84	0.00	9.96	23.24	20.56	0.00	9.42	19.20	32.34
P/Operating CF Full definition →	79.63	68.83	155.09	20.83	57.97	1,869.86	(168.39)	54.99	58.09	71.13
P/B ratio Full definition →	3.59	2.36	1.78	1.86	1.95	1.42	1.61	3.19	4.55	3.90
Price to Tangible BV Full definition →	5.30	4.27	4.20	8.00	4.88	0.00	2.80	8.03	27.68	34.54
EV/Sales Full definition →	12.48	10.17	8.27	5.04	6.56	6.38	6.70	6.58	13.19	13.15
EV/EBITDA Full definition →	47.07	144.18	22.93	17.87	9.23	11.59	0.93	7.62	20.37	21.57
EV/Operating CF Full definition →	67.79	17.51	21.92	7.17	20.10	19.11	(27.47)	8.52	21.01	23.60
EV/FCF Full definition →	54.93	18.94	(281.92)	8.84	22.98	21.36	(22.97)	8.70	19.64	34.80
Quick Ratio Full definition →	21.83	8.32	12.49	2.50	10.39	4.70	65.38	10.09	0.95	0.69
Current Ratio Full definition →	22.23	8.93	14.15	2.67	11.15	5.00	66.09	10.58	0.99	0.72
Net Debt/EBITDA Full definition →	(4.36)	(22.58)	(3.59)	(2.26)	(0.11)	0.43	(0.49)	(0.63)	0.46	1.53
Debt/Assets Full definition →	28.59%	0.00%	0.00%	11.37%	24.79%	33.05%	42.81%	50.47%	36.27%	40.31%
Debt/Equity Full definition →	0.44	0.00	0.00	0.15	0.39	0.63	0.83	1.13	0.61	0.71
Asset Turnover Full definition →	0.21	0.19	0.17	0.19	0.18	0.11	0.09	0.26	0.22	0.20
Operating CF/Net income Full definition →	0.40	(24.07)	0.95	(4.13)	1.38	(18.29)	(0.05)	1.35	7.05	(37.12)
Capex/Depreciation Full definition →	(0.03)	(0.35)	(1.51)	(0.34)	(0.12)	(0.06)	(0.04)	(0.20)	0.21	(0.87)
Interest Coverage Full definition →	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ROE Full definition →	13.47%	(0.53%)	8.03%	(4.70%)	7.47%	(0.40%)	94.76%	29.84%	3.39%	(0.57%)
ROA Full definition →	9.95%	(0.47%)	6.73%	(3.24%)	4.30%	(0.21%)	45.67%	14.84%	1.97%	(0.30%)
ROIC Full definition →	3.62%	(2.50%)	1.41%	0.40%	8.10%	3.13%	149.54%	24.17%	9.64%	6.20%
Return on Tangible Assets Full definition →	15.66%	(1.30%)	22.08%	(18.82%)	13.10%	(0.72%)	56.50%	18.06%	530.91%	2.63%
Average Days of Receivables Full definition →	83.12	92.70	109.27	65.17	138.49	131.81	126.69	81.28	66.21	49.24
Research and Development Expense of Revenue Full definition →	30.28%	12.82%	18.69%	18.39%	13.29%	24.76%	46.48%	11.08%	19.06%	19.47%
Selling, General and Administrative Expense of Revenue Full definition →	34.48%	47.06%	40.20%	35.70%	19.37%	36.69%	34.82%	15.01%	20.31%	25.38%
Intangible Assets out of Total Assets Full definition →	0.21	0.39	0.51	0.60	0.38	0.58	0.22	0.27	0.50	0.50
Share Based Compensation of Revenue Full definition →	17.48%	24.58%	19.60%	30.72%	16.06%	18.79%	20.38%	8.29%	17.66%	17.34%
Graham Net Nets Full definition →	0.08	0.11	0.12	0.09	(0.01)	(0.15)	0.32	0.10	(0.02)	(0.07)
Graham Number Full definition →	86.35	0.00	52.64	0.00	62.00	0.00	166.79	63.45	16.02	0.00
Earnings Yield Full definition →	3.33%	(0.05%)	4.20%	(3.00%)	3.59%	(0.23%)	47.05%	7.97%	0.69%	(0.09%)
Free Cash Flow Yield Full definition →	1.67%	4.58%	(0.31%)	10.04%	4.30%	4.86%	(2.84%)	10.61%	5.21%	3.09%
Revenue per Share Full definition →	13.86	9.14	7.59	11.63	14.52	10.11	6.33	11.88	6.71	5.23
Operating CF per Share Full definition →	2.55	5.31	2.87	8.17	4.74	3.37	(1.54)	9.17	4.21	2.92
Capex per Share Full definition →	(0.05)	(0.67)	(3.09)	(1.06)	(0.50)	(0.19)	(0.13)	(0.51)	0.23	(0.94)
Free Cash Flow per Share Full definition →	2.50	4.64	(0.22)	7.12	4.24	3.18	(1.68)	8.66	4.44	1.98
Cash per Share Full definition →	39.11	14.55	9.85	12.56	20.51	25.41	56.32	36.57	9.59	6.77
Shareholders Equity per Share Full definition →	52.60	45.40	40.52	35.42	49.38	43.84	40.39	26.51	19.01	16.38
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book value per Share Full definition →	52.60	45.40	40.52	35.42	49.38	43.84	40.39	26.51	19.01	16.38
Free Cash Flow Full definition →	48.31	84.84	(3.85)	120.02	70.53	51.49	(31.89)	183.17	93.47	41.19
Working Capital Full definition →	794.82	294.45	220.65	164.79	423.09	400.45	1,106.64	788.29	(1.85)	(64.08)
Capital Expenditures Full definition →	(1.05)	(12.21)	(53.43)	(17.83)	(8.27)	(3.10)	(2.55)	(10.89)	4.90	(19.54)
Net Current Asset Value Full definition →	288.85	220.22	151.13	98.42	(11.68)	(152.20)	395.96	170.65	(34.21)	(97.24)
EV/EBIT Full definition →	81.61	0.00	90.98	325.52	15.25	27.82	1.00	10.10	27.33	32.66
Capex to Sales Full definition →	0.00	0.07	0.41	0.09	0.03	0.02	0.02	0.04	(0.03)	0.18
Net Profit Margin Full definition →	46.42%	(2.41%)	39.72%	(17.00%)	23.66%	(1.82%)	523.19%	57.00%	8.90%	(1.50%)
Price to Operating Income Full definition →	89.17	0.00	104.74	366.74	15.43	26.78	1.53	10.94	26.72	30.35
Other line items
Depreciation/Fixed assets Full definition →	0.00	2.27	2.27	4.19	5.14	3.64	8.83	9.91	5.52	12.40
Cash ROIC Full definition →	2.22%	7.47%	3.90%	13.99%	4.42%	2.56%	(1.47%)	9.57%	9.99%	8.13%
Accounts Receivable Turnover Full definition →	5.18	4.09	3.53	3.10	3.21	3.24	2.46	6.16	7.00	10.44
Accounts Payable Turnover Full definition →	3.44	2.89	2.72	7.71	10.20	9.81	3.44	1.97	2.15	1.63
Inventory Turnover Full definition →	1.25	0.58	0.56	2.60	2.31	1.80	1.57	1.10	1.70	3.13
Average Days of Payables Full definition →	81.23	172.48	84.27	36.67	49.33	45.40	77.84	240.93	153.66	179.13
Days of Inventory on Hand Full definition →	228.95	465.20	832.26	91.85	160.42	317.82	234.69	410.33	297.46	125.99
Average Receivables Full definition →	51.75	40.88	37.18	63.34	75.36	50.41	48.87	40.79	20.15	10.44
Average Payables Full definition →	4.24	3.83	3.87	6.86	6.09	3.10	3.30	3.22	2.50	3.41
Average Inventory Full definition →	11.62	19.04	18.63	20.31	26.91	16.89	7.21	5.75	3.15	1.78
Average Assets Full definition →	1,251.21	864.50	774.94	1,030.13	1,329.94	1,428.60	1,377.86	965.91	636.30	552.32
Average Common Equity Full definition →	923.83	765.68	649.20	709.32	765.34	738.38	664.07	480.35	370.54	289.29

Fold the line items

Columns are period end dates

Powerpack

Full quarterly history

Analyst estimates

Unlimited screener

Unlimited Excel

Unlimited follows

Ligand Pharmaceuticals Incorporated LGND

Ligand Pharmaceuticals Incorporated LGND

Stockrow Weekly